Argyrios G. Arvanitis

Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans

Adam D. Shilling, Frank M. Nedza, Thomas Emm et al. · Drug Metabolism and Disposition · 2010 · 107 citations

Non-Peptide Corticotropin-Releasing Hormone Antagonists:  Syntheses and Structure−Activity Relationships of 2-Anilinopyrimidines and -triazines

Argyrios G. Arvanitis, Paul J. Gilligan, Robert J. Chorvat et al. · Journal of Medicinal Chemistry · 1999 · 74 citations · Full text

Corticotropin-Releasing Hormone Receptor Antagonists:  Framework Design and Synthesis Guided by Ligand Conformational Studies

C. Nicholas Hodge, Paul E. Aldrich, Zelda R. Wasserman et al. · Journal of Medicinal Chemistry · 1999 · 69 citations · Full text

Crh1 Receptor Antagonists, Receptor-bound Conformation, Chemical Biology +20

Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmacokinetic Properties of Triazolo-, Imidazo-, and Pyrrolopyrimidines and -pyridines

Robert J. Chorvat, Rajagopal Bakthavatchalam, James P. Beck et al. · Journal of Medicinal Chemistry · 1999 · 63 citations · Full text

Synthesis and evaluation of 2-anilino-3-phenylsulfonyl-6-methylpyridines as corticotropin-releasing factor1 receptor ligands

Richard A. Hartz, Argyrios G. Arvanitis, Charles R. Arnold et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 63 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +5